Technology promotion, the pathophysiological role of JunB/AP-1 in Mulitiplen Mylom (Q6872762)

From EU Knowledge Graph
Revision as of 11:50, 7 December 2023 by DG Regio (talk | contribs) (‎Changed an Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Project GENERATED-ID-2014AT16RFOP001-2023-11-21-2783 in Austria
Language Label Description Also known as
English
Technology promotion, the pathophysiological role of JunB/AP-1 in Mulitiplen Mylom
Project GENERATED-ID-2014AT16RFOP001-2023-11-21-2783 in Austria

    Statements

    0 references
    248,550.0 Euro
    0 references
    1 October 2018
    0 references
    30 September 2022
    0 references
    Karl Landsteiner Privatuniversität für Gesundheitswissenschaften GmbH
    0 references
    0 references
    Pathophysiologische Rolle von JunB/AP-1 im Mulitiplen Mylom - Grundlage für eine innovative Medikamenten-Entwicklung (German)
    0 references
    Патофизиологична роля на JunB/AP-1 в Mulitiplen mylom — основа за иновативно разработване на лекарства (Bulgarian)
    0 references
    Patofyziologická role JunB/AP-1 v Mulitiplen mylomu – základ pro inovativní vývoj léčiv (Czech)
    0 references
    JunB/AP-1's patofysiologiske rolle i Mulitiplen mylom — grundlag for innovativ lægemiddeludvikling (Danish)
    0 references
    Παθοφυσιολογικός ρόλος του JunB/AP-1 στο Mulitiplen mylom — βάση για την καινοτόμο ανάπτυξη φαρμάκων (Greek)
    0 references
    Pathophysiological role of JunB/AP-1 in Mulitiplen mylom – basis for innovative drug development (English)
    0 references
    Papel fisiopatológico de JunB/AP-1 en Mulitiplen mylom — base para el desarrollo innovador de fármacos (Spanish)
    0 references
    JunB/AP-1 patofüsioloogiline roll Mulitiplen mylomis – innovatiivsete ravimite väljatöötamise alus (Estonian)
    0 references
    JunB/AP-1:n patofysiologinen rooli Mulitiplen mylomissa – perusta innovatiiviselle lääkekehitykselle (Finnish)
    0 references
    Rôle pathophysiologique de JunB/AP-1 dans le mylome mulitiplène — Base d’un développement innovant de médicaments (French)
    0 references
    Ról paitifiseolaíoch JunB/AP-1 i Mulitiplen mylom — bunús d’fhorbairt nuálach drugaí (Irish)
    0 references
    Patofiziološka uloga JunB/AP-1 u Mulitiplen mylomu – osnova za razvoj inovativnih lijekova (Croatian)
    0 references
    A JunB/AP-1 patofiziológiai szerepe a Mulitiplen mylomban – az innovatív gyógyszerfejlesztés alapja (Hungarian)
    0 references
    Ruolo patofisiologico di JunB/AP-1 in Mulitiplen mylom — base per lo sviluppo di farmaci innovativi (Italian)
    0 references
    Patofiziologinis JunB/AP-1 vaidmuo Mulitiplen mylom – naujoviškų vaistų kūrimo pagrindas (Lithuanian)
    0 references
    JunB/AP-1 patofizioloģiskā loma Mulitiplen mylom — inovatīvu zāļu izstrādes pamats (Latvian)
    0 references
    Ir-rwol patofiżjoloġiku ta ‘JunB/AP-1 fil Mulitiplen mylom — bażi għall-iżvilupp innovattiv tad-droga (Maltese)
    0 references
    Pathofysiologische rol van JunB/AP-1 in Mulitiplen mylom — basis voor innovatieve ontwikkeling van geneesmiddelen (Dutch)
    0 references
    Papel fisiopatológico de JunB/AP-1 no mulitiplen mylom — base para o desenvolvimento inovador de fármacos (Portuguese)
    0 references
    Rolul fiziopatologic al JunB/AP-1 în milomul Mulitiplen – baza pentru dezvoltarea inovatoare a medicamentelor (Romanian)
    0 references
    Patofyziologická úloha JunB/AP-1 v Mulitiplen mylom – základ pre inovatívny vývoj liekov (Slovak)
    0 references
    Patofiziološka vloga JunB/AP-1 v Mulitiplen mylom – osnova za razvoj inovativnih zdravil (Slovenian)
    0 references
    Patofysiologisk roll JunB/AP-1 i Mulitiplen mylom – grund för innovativ läkemedelsutveckling (Swedish)
    0 references
    22 November 2023
    0 references
    7 December 2023
    0 references

    Identifiers

    GENERATED-ID-2014AT16RFOP001-2023-11-21-2783
    0 references